SHARE-BASED COMPENSATION (SARS Activity) (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)	12 Months Ended
	Jan. 28, 2017	Jan. 30, 2016
Number of Underlying Shares Outstanding [Roll Forward]
Number of Underlying Shares, Outstanding (in shares)	4,079,050	5,301,115
Number of Underlying Shares, Granted (in shares)	0
Number of Underlying Shares, Exercised (in shares)	(10,483)
Number of Underlying Shares, Forfeited or expired (in shares)	(1,211,582)
Weighted-Average Exercise Price [Roll Forward]
Weighted-Average Exercise Price, Outstanding (in dollars per share)	$ 47.49	$ 45.02
Weighted-Average Grant Date Fair Value, Granted (in dollars per share)	0.00
Weighted-Average Exercise Price, Exercised (in dollars per share)	22.45
Weighted-Average Exercise Price, Forfeited or exercised (in dollars per share)	$ 37.19
Aggregate Intrinsic Value, Outstanding	$ 0
Weighted-Average Remaining Contractual Life, Outstanding	2 years 7 months 6 days
Number of Underlying Shares, Stock appreciation rights exercisable (in shares)	3,532,119
Weighted-Average Exercise Price, Stock appreciation rights exercisable (in dollars per share)	$ 50.62
Aggregate Intrinsic Value, Stock appreciation rights exercisable	$ 0
Weighted- Average Remaining Contractual Life, Stock appreciation rights exercisable	1 year 10 months 24 days
Number of Underlying Shares, Stock appreciation rights expected to become exercisable (in shares)	436,030
Weighted-Average Exercise Price, Stock appreciation rights expected to become exercisable (in dollars per share)	$ 27.72
Aggregate Intrinsic Value, Stock appreciation rights expected to become exercisable	$ 0
Weighted-Average Remaining Contractual Life, Stock appreciation rights expected to become exercisable	7 years 8 months 12 days